| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/14651858.CD004079.PUB2 |
| P698 | PubMed publication ID | 15106236 |
| P2093 | author name string | Robin S McLeod | |
| Tracey K. Asano | |||
| P2860 | cites work | Translational studies on Cox-2 inhibitors in the prevention and treatment of colon cancer | Q74057711 |
| APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings | Q28188702 | ||
| Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis | Q28191273 | ||
| Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis | Q28192057 | ||
| Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force | Q28192096 | ||
| A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer | Q28195274 | ||
| A randomized trial of aspirin to prevent colorectal adenomas | Q28195296 | ||
| Randomised study of screening for colorectal cancer with faecal-occult-blood test | Q29037307 | ||
| The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis | Q29616121 | ||
| Randomised controlled trial of faecal-occult-blood screening for colorectal cancer | Q29999461 | ||
| Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study | Q32066768 | ||
| Do NSAIDs prevent colorectal cancer? | Q33911600 | ||
| The coxibs, selective inhibitors of cyclooxygenase-2. | Q34086325 | ||
| Risk of cardiovascular events associated with selective COX-2 inhibitors | Q34087109 | ||
| Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study | Q34363424 | ||
| Sulindac causes regression of rectal polyps in familial adenomatous polyposis | Q34565164 | ||
| Natural history of untreated colonic polyps. | Q34691452 | ||
| Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup | Q34728738 | ||
| Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis | Q34729756 | ||
| Screening sigmoidoscopy and colorectal cancer mortality | Q35393813 | ||
| Primary chemoprevention of familial adenomatous polyposis with sulindac | Q36426993 | ||
| Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects | Q39295295 | ||
| Aetiology of adenoma--carcinoma sequence in large bowel | Q39472358 | ||
| Aspirin and the prevention of colorectal cancer: a review of the evidence | Q40702250 | ||
| Participation in colorectal cancer screening: a review | Q40879795 | ||
| Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study | Q43903198 | ||
| Effect of sulindac on sporadic colonic polyps. | Q46204309 | ||
| Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. | Q52423909 | ||
| Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis. | Q54575760 | ||
| Rectal cancer in FAP patient after sulindac. | Q54642853 | ||
| Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. | Q54647090 | ||
| Design of the Women’s Health Initiative Clinical Trial and Observational Study | Q56483522 | ||
| The protocol for a european double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: The capp study | Q57316239 | ||
| Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study | Q68123711 | ||
| Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy | Q72164397 | ||
| Low-dose aspirin and incidence of colorectal tumors in a randomized trial | Q72832103 | ||
| Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study | Q73280179 | ||
| Chemoprevention: What's in a name? | Q73883081 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| inflammation | Q101991 | ||
| P304 | page(s) | CD004079 | |
| P577 | publication date | 2004-01-26 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Non steroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas |
| Q58047188 | A prospective evaluation of C-peptide levels and colorectal adenoma incidence |
| Q37085352 | Apoptosis in normal rectal mucosa, baseline adenoma characteristics, and risk of future adenomas |
| Q34514217 | Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study |
| Q37427885 | Chemoprevention for colorectal neoplasia |
| Q38674336 | Chemoprevention of colorectal neoplasia |
| Q27026428 | Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer |
| Q38973304 | Clonal evolution of colorectal cancer in IBD. |
| Q37795256 | Colorectal Cancer: What Should Patients and Families Be Told to Lower the Risk of Colorectal Cancer? |
| Q30726318 | Colorectal cancer predicted risk online (CRC-PRO) calculator using data from the multi-ethnic cohort study |
| Q38827631 | Comparative effectiveness of chemopreventive interventions for colorectal cancer: protocol for a systematic review and network meta-analysis of randomised controlled trials. |
| Q57165445 | Cruciferous Vegetables, Isothiocyanates, and Bladder Cancer Prevention |
| Q26799039 | Duodenal adenoma surveillance in patients with familial adenomatous polyposis |
| Q45720383 | Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials. |
| Q33739788 | Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials |
| Q42582205 | Gastric mucosal metastasis from primary colorectal carcinoma |
| Q30984696 | Handling missing data in matched case-control studies using multiple imputation |
| Q41695479 | Influence of NSAID Use Among Colorectal Cancer Survivors on Cancer Outcomes |
| Q41404998 | Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial |
| Q37172368 | Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. |
| Q33874772 | Polyp size measurement at CT colonography: what do we know and what do we need to know? |
| Q47720507 | Potent suppression of both spontaneous and carcinogen-induced colitis-associated colorectal cancer in mice by dietary celastrol supplementation |
| Q33976246 | Primary and secondary prevention of colorectal cancer |
| Q80352873 | Rectal bleeding and previous anticoagulant treatment in patients with colorectal cancer do not predict outcome |
| Q28200524 | Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis |
| Q43493272 | Statin use is associated with a reduced incidence of colorectal adenomatous polyps |
| Q34244183 | Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case-control study |
Search more.